4
Views
0
CrossRef citations to date
0
Altmetric
CORRESPONDENCE

Late recurrence of an ovarian yolk sac tumour as a carcinosarcoma

, &
Pages 601-603 | Published online: 06 Jul 2009

  • Michael H., Lucia J., Foster R. S., Ulbright T. M. The pathology of late recurrence of testicular germ cell tumours. Am J Surg Pathol 2000; 24: 257–73
  • Tucker M. A., Meadows A. T., Boice J. D Jr., et al. Leukaemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987; 78: 459–64
  • Robinson E., Neugut A. I., Wylie P. Clinical aspects of post irradiation sarcomas. J Natl Cancer Inst 1988; 80: 233–40
  • Berney D. M., Shamash J., Pieroni K., Oliver R. T. D. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?. Histopathology 2001; 39: 382–5
  • Nawa N., Abata N., Kikkawa F., et al. Prognostic factors of patients with yolk sac tumours of the ovary. Am J Obstet Gynecol 2001; 184: 1182–8
  • Tewari K., Cappuccini F., Disaia P. J., Berman M. L., Manetta A., Kohler M. F. Malignant germ cell tumours of the ovary. Obstet Gynecol 2000; 95: 128–33
  • Kommoss F., Schmidt M., Merz E., Knapstein P. G., Young R. H., Scully R. E. Ovarian endometrioid‐like yolk sac tumour treated by surgery alone, with recurrence at 12 years. Gynecol Oncol 1999; 72: 421–4
  • Damjanov I., Amenta P. S., Zarghanmi F. Transformation of an AFP‐positive yolk sac carcinoma into an AFP‐negative neoplasm. Evidence for in vivo cloning of human parietal yolk sac carcinoma. Cancer 1984; 53: 1902–7
  • Stenning S. P., Parkinson M. C., Fisher C., et al. Postchemotherapy residual masses in germ cell tumor patients. Cancer 1998; 83: 1409–19
  • Berney D. M., Shamash J., Hendry W. F., Arora A., Jordan S., Oliver R. T. Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?. Br J Cancer 2001; 84: 340–3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.